Dernek Hakkında Tıbbi Onkoloji Derneği Haberler

Journal of Clinical Oncology - Ağustos 2010


Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos,  Dimitrios Spentzos,  Beth Y. Karlan,  Toshiyasu Taniguchi,  Elena Fountzilas,  Nancy Francoeur,  Douglas A. Levine,  and Stephen A. Cannistra     

Phase II, Open-Label Study of Pazopanib or Lapatinib Monotherapy Compared With Pazopanib Plus Lapatinib Combination Therapy in Patients With Advanced and Recurrent Cervical Cancer
Bradley J. Monk, Luis Mas Lopez, Juan J. Zarba, Ana Oaknin, Carole Tarpin, Wichai Termrungruanglert, Jacquelyn A. Alber,

  Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
Philip A. Philip,  Jacqueline Benedetti,  Christopher L. Corless,  Ralph Wong,  Eileen M. O'Reilly,  Patrick J. Flynn,  Kendrith M. Rowland,  James N. Atkins,  Barry C. Mirtsching,  Saul E. Rivkin,  Alok A. Khorana,  Bryan Goldman,  Cecilia M. Fenoglio-Preiser,

 Pain and Emotional Well-Being Outcomes in Southwest Oncology Group–Directed Intergroup Trial S0205: A Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine As First-Line Therapy in Patients With Advanced Pancreas Cancer 
Carol M. Moinpour,  Nancy L. Vaught,  Bryan Goldman,  Mary W. Redman,  Philip A. Philip,  Barbara Millwood,  Scott M. Lippman,  Thomas E. Seay,  Patrick J. Flynn,  Eileen M. O'Reilly,  Kendrith M. Rowland,  Ralph P. Wong,  Jacqueline Benedetti,  and Charles D. Blanke 

 Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) 
Hedy Lee Kindler,  Donna Niedzwiecki,  Donna Hollis,  Susan Sutherland,  Deborah Schrag,  Herbert Hurwitz,  Federico Innocenti,  Mary Frances Mulcahy,  Eileen O'Reilly,  Timothy F. Wozniak,  Joel Picus,  Pankaj Bhargava,  Robert J. Mayer,  Richard L.


 The Birth of the Subspecialty of Medical Oncology and Examples of Its Early Scientific Foundations
Pierre R. Band 


 Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Amanda R. Moraska,  Amit Sood,  Shaker R. Dakhil,  Jeff A. Sloan,  Debra Barton,  Pamela J. Atherton,  Jason J. Suh,  Patricia C. Griffin,  David B. Johnson,  Aneela Ali,  Peter T. Silberstein,  Steven F. Duane,  and Charles L. Loprinzi 

Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
Alain Hendlisz,  Marc Van den Eynde,  Marc Peeters,  Geert Maleux,  Bieke Lambert,  Jaarke Vannoote,  Katrien De Keukeleire,  Chris Verslype,  Luc Defreyne,  Eric Van Cutsem,  Philippe Delatte,  Thierry Delaunoit,  Nicola Personeni,  Marianne Paesmans,

High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma
Franck Morschhauser,  Françoise Kraeber-Bodéré,  William A. Wegener,  Jean-Luc Harousseau,  Marie-Odile Petillon,  Damien Huglo,  Lorenz H. Trümper,  Johannes Meller,  Michael Pfreundschuh,  Carl-Martin Kirsch,  Ralph Naumann,  Joachim Kropp,  Heather Horne,  Nick Teoh,  Steven Le Gouill,  Caroline Bodet-Milin,  Jean-Francois Chatal,  and David M. Goldenberg 

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105
Nobuyuki Yamamoto,  Kazuhiko Nakagawa,  Yasumasa Nishimura,  Kayoko Tsujino,  Miyako Satouchi,  Shinzoh Kudo,  Toyoaki Hida,  Masaaki Kawahara,  Koji Takeda,  Nobuyuki Katakami,  Toshiyuki Sawa,  Soichiro Yokota,  Takashi Seto,  Fumio Imamura,  Hideo Saka,  Yasuo Iwamoto,  Hiroshi Semba,  Yasutaka Chiba,  Hisao Uejima,  and Masahiro Fukuoka 


American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer
Harold J. Burstein,  Ann Alexis Prestrud,  Jerome Seidenfeld,  Holly Anderson,  Thomas A. Buchholz,  Nancy E. Davidson,  Karen E. Gelmon,  Sharon H. Giordano,  Clifford A. Hudis,  Jennifer Malin,  Eleftherios P. Mamounas,  Diana Rowden,  Alexander J. Solky,  MaryFran R. Sowers,  Vered Stearns,  Eric P. Winer,  Mark R. Somerfield,  and Jennifer J. Griggs


Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study
Wendy B. London,  Christopher N. Frantz,  Laura A. Campbell,  Robert C. Seeger,  Babette A. Brumback,  Susan L. Cohn,  Katherine K. Matthay,  Robert P. Castleberry,  and Lisa Diller 

Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study
Lance C. Pagliaro,  Dallas L. Williams,  Danai Daliani,  Michael B. Williams,  William Osai,  Michael Kincaid,  Sijin Wen,  Peter F. Thall,  and Curtis A. Pettaway